Home » Topics » Regulatory » Patents

Patents
RSS

Merck Frosst discloses leukotriene antagonists

Feb. 12, 1997

AGE inhibitors reported by Alteon

Feb. 12, 1997

Anticonvulsants with favorable protection indices reported by Canadian researchers

Feb. 12, 1997

Teva presents potential antipsoriatic agents

Feb. 12, 1997

Diagnostic MAbs from Terumo

Feb. 11, 1997

Sumitomo develops ACAT inhibitors

Feb. 11, 1997

Eisai synthesizes heterocyclic anticancer compounds

Feb. 11, 1997

Hypoglycemic/hypolipidemic agents from Kyorin

Feb. 11, 1997

Takeda prepares NO production inhibitors

Feb. 11, 1997

Sankyo develops antidiabetic agents

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...